What are Harmony Biosciences Holdings, Inc.'s profit margins?

Harmony Biosciences Holdings, Inc. (HRMY) runs a 76.5% gross margin and a 21.1% operating margin, with a 16.2% net margin.

Where do Harmony Biosciences Holdings, Inc.'s ratios come from?

Every ratio is computed from Harmony Biosciences Holdings, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Harmony Biosciences Holdings, Inc. HRMY Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	76.5%-0.6pp	77.2%-0.5pp	77.7%-0.6pp	78.3%0.0pp	78.3%+0.3pp
Operating margin	21.1%-2.9pp	24%-3.3pp	27.3%-1.4pp	28.7%+2.5pp	26.2%-0.5pp
Net margin	16.2%-2.1pp	18.3%-4.2pp	22.5%-0.9pp	23.4%+2.9pp	20.5%+0.1pp
EBITDA margin	23.7%-3.0pp	26.8%-3.5pp	30.2%-1.6pp	31.8%+2.4pp	29.4%-0.7pp
Returns
Return on equity	17.9%-2.9pp	20.8%-5.2pp	25.9%-1.7pp	27.6%+2.9pp	24.7%-1.1pp
Return on assets	12.5%-1.5pp	14%-3.4pp	17.4%-1.0pp	18.4%+2.3pp	16.1%0.0pp
Return on invested capital	31.2%-14.4pp	45.6%-2.7pp	48.3%+4.3pp	44%+5.5pp	38.5%-0.7pp
Efficiency
Asset turnover	0.8×0.0×	0.8×0.0×	0.8×0.0×	0.8×0.0×	0.8×0.0×
Inventory turnover	36.2×+4.6×	31.6×+4.9×	26.7×-1.8×	28.5×+2.1×	26.4×+1.4×
Liquidity
Current ratio	3.6×0.0×	3.6×-0.2×	3.8×-0.1×	3.8×+0.2×	3.7×+0.4×
Quick ratio	3.6×0.0×	3.6×-0.1×	3.7×-0.1×	3.8×+0.2×	3.6×+0.4×
Cash ratio	2.7×-0.3×	3×+0.1×	2.9×-0.1×	3×+0.2×	2.8×+0.2×
Leverage
Debt-to-equity	0.2×0.0×	0.2×0.0×	0.2×0.0×	0.2×0.0×	0.2×0.0×
Debt-to-assets	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.2×0.0×	0.2×0.0×
Net debt / EBITDA	-2×+0.5×	-2.5×-0.6×	-1.9×-0.4×	-1.5×-0.1×	-1.4×-0.2×
Interest coverage	13.5×-0.7×	14.2×-0.5×	14.7×+0.9×	13.8×+2.2×	11.6×+0.7×
Per Share
Book value per share	$15.49+4.2%	$14.86+4.5%	$14.22+7.5%	$13.23+7.5%	$12.31+8.1%
Valuation
Market capitalization	$1.62B-24.8%	$2.16B+35.9%	$1.59B-13.9%	$1.84B-3.3%	$1.9B-3.0%
Enterprise value	$1.2B-24.0%	$1.57B+41.8%	$1.11B-24.5%	$1.47B-7.8%	$1.59B-5.9%
Price / earnings	11.1×-2.5×	13.6×+5.0×	8.5×-1.6×	10.2×-2.3×	12.5×-1.0×
Price / sales	1.8×-0.7×	2.5×+0.6×	1.9×-0.5×	2.4×-0.2×	2.6×-0.2×
Price / book	1.8×-0.7×	2.5×+0.6×	1.9×-0.5×	2.4×-0.3×	2.6×-0.3×
EV / EBITDA	5.6×-1.2×	6.8×+2.3×	4.4×-1.5×	6×-1.3×	7.3×-0.6×
EV / sales	1.3×-0.5×	1.8×+0.5×	1.3×-0.6×	1.9×-0.2×	2.1×-0.2×
Earnings yield	9%+1.6pp	7.4%-4.3pp	11.7%+1.9pp	9.8%+1.8pp	8%+0.6pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Harmony Biosciences Holdings, Inc.'s profit margins?: Harmony Biosciences Holdings, Inc. (HRMY) runs a 76.5% gross margin and a 21.1% operating margin, with a 16.2% net margin.
Where do Harmony Biosciences Holdings, Inc.'s ratios come from?: Every ratio is computed from Harmony Biosciences Holdings, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.